News & Events

Dotmed Health Care Business News Magazine article

Cubresa is pleased to be featured in Dotmed’s Health Care Business News Magazine – June 2020 edition.

The article, found on page 56, focuses on innovation in the PET and SPECT markets. Dr. James Schellenberg, Cubresa’s Founder and CEO is pleased to share information highlighting the value of its NuPET preclinical insert for SARS-CoV-2 research in BSL 3 environments, as well as applications for the clinical BrainPET insert currently under development. To read more, please click on the following link.

Dotmed Article

 

Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.

Company

About Us
Leadership
Technology

Location

Cubresa Inc.
1116 Sanford St.
Winnipeg, MB, Canada
R3E 2Z9

1-204-272–2409

Products

Clinical:

Preclinical:

Contact

Request more information

Follow Us